Pharmaceutical giant GSK invests in British sites

Pharmaceutical giant GSK invests in British sites


" GlaxoSmithKline is investing some 275 million pounds into three plants in Britain, sweeping aside concerns about growth following the country's decision to leave the European Union. The pharmaceutical giant's chief executive Andrew Witty said Tuesday that the Britain's "competitive corporate tax system" and skilled workforce influenced the decision to invest in the manufacturing of new respiratory and large molecule biological medicines.



from Biotech News